Preliminary results for the phase 1 trial of a folate receptor alpha adjuvant cancer vaccine in ovarian and endometrial cancer patients

Παρόμοια τεκμήρια

• Preliminary results of the Phase IIa trial of a folate binding protein (FBP) adjuvant cancer vaccine (E39+GM-CSF) in ovarian and endometrial cancer patients to prevent recurrence
  ανά: Greene, Julia, κ.ά.
  Έκδοση: (2014)
• Vaccine-specific T-cell proliferation in response to a dual peptide cancer vaccine in breast and ovarian cancer patients
  ανά: Schneble, Erika J, κ.ά.
  Έκδοση: (2013)
• Correlation of HER2/neu antibody response to clinical response in a Phase II trial of the ae37+gm-csf her2 peptide vaccine
  ανά: Greene, Julia, κ.ά.
  Έκδοση: (2014)
• Interim analysis of a phase I/IIa trial assessing E39+GM-CSF, a folate binding protein vaccine, to prevent recurrence in ovarian and endometrial cancer patients
  ανά: Jackson, Doreen O., κ.ά.
  Έκδοση: (2016)
• Preliminary report of a clinical trial supporting the sequential use of an attenuated E39 peptide (E39') to optimize the immunologic response to the FBP (E39+GM-CSF) vaccine
  ανά: Jackson, Doreen, κ.ά.
  Έκδοση: (2015)